Efficacy of Adipocyte-Derived Stem Cells-Conditioned Media in Telogen Effluvium.

Published in: Stem cells and cloning : advances and applications (2023)

ADSC-CM was successfully applied as a new treatment option for patients with telogen effluvium. These findings provide another therapeutic and research area for dermatologists to optimize the management of telogen effluvium and reduce its impact on patients.

Keyphrases

stem cells
end stage renal disease
ejection fraction
newly diagnosed
adipose tissue
prognostic factors
peritoneal dialysis
patient reported outcomes
metabolic syndrome
mesenchymal stem cells
fatty acid
combination therapy
smoking cessation
replacement therapy